RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/43437
https://w3id.org/ripe/ripe-kg/retraction-notice/43437
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA084C6EAC9724305F |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA08F1214EC0C80369 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA0C83AF9CE6274D42 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA1CF9367F3C1B1AFC |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA233158DEF9C3F087 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA323E9769EC8E8E48 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA3DB7B5186353EACB |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA4A841AC6ADD4DA5B |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA4BED4D9BD987577D |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA534C4E03EC302AE0 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA55912887A066C004 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA56FDC28B3E9006DE |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA69C9C09037F4A7D7 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA84BEB5719212517B |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA85E75680E0A580E5 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA8DB1A5C7D4B2BCF0 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA95D9EF8B2CE9BCA4 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEA9FB7C0468A11295E |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEAC29393890CA84E8D |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEAC60164BBD59BB4A3 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEAE59AF25CB9D16527 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEAF6AAC41E3D64BA2C |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:evaluation/RIPEAF7E1928294A86E83 |
prov:used |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prism:doi |
10.1017/s0007114521002439 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prism:publicationDate |
2021-08-06 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prism:publicationName |
British Journal of Nutrition |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
dcterms:publisher |
ripekg:publisher/RIPEP2AE51BF9B0CC6EC1Cambridge University Press |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
dcterms:title |
Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1017%2Fs0007114519001132 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
rdf:type |
owl:Thing |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
owl:sameAs |
https://semopenalex.org/work/W3187317430 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA084C6EAC9724305F |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA08F1214EC0C80369 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA0C83AF9CE6274D42 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA1CF9367F3C1B1AFC |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA233158DEF9C3F087 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA323E9769EC8E8E48 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA3DB7B5186353EACB |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4A841AC6ADD4DA5B |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4BED4D9BD987577D |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA534C4E03EC302AE0 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA55912887A066C004 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA56FDC28B3E9006DE |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA69C9C09037F4A7D7 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA84BEB5719212517B |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA85E75680E0A580E5 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA8DB1A5C7D4B2BCF0 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA95D9EF8B2CE9BCA4 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA9FB7C0468A11295E |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAC29393890CA84E8D |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAC60164BBD59BB4A3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAE59AF25CB9D16527 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAF6AAC41E3D64BA2C |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAF7E1928294A86E83 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA084C6EAC9724305F |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA08F1214EC0C80369 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA0C83AF9CE6274D42 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA1CF9367F3C1B1AFC |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA233158DEF9C3F087 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA323E9769EC8E8E48 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA3DB7B5186353EACB |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA4A841AC6ADD4DA5B |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA4BED4D9BD987577D |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA534C4E03EC302AE0 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA55912887A066C004 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA56FDC28B3E9006DE |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA69C9C09037F4A7D7 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA84BEB5719212517B |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA85E75680E0A580E5 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA8DB1A5C7D4B2BCF0 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA95D9EF8B2CE9BCA4 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA9FB7C0468A11295E |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAC29393890CA84E8D |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAC60164BBD59BB4A3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAE59AF25CB9D16527 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAF6AAC41E3D64BA2C |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAF7E1928294A86E83 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripe:concerns |
ripekg:author/RIPEAU12AB7F7324C8BC37Mohsen Taghizadeh |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripe:concerns |
ripekg:author/RIPEAU5C3291F99AC2A103Vahidreza Ostadmohammadi |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripe:concerns |
ripekg:author/RIPEAU74D042D0ABC375B6Mohsen Taghizadeh |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripe:concerns |
ripekg:author/RIPEAU7BBF56A1DB061B3DFariba Raygan |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripe:concerns |
ripekg:author/RIPEAU921E052D3378AED8Hamid Talari |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripe:concerns |
ripekg:author/RIPEAU93D1913D4289C9C6Elaheh Amirani |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripe:concerns |
ripekg:author/RIPEAU9FA3E917EB998375Naghmeh Mirhosseini |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripe:concerns |
ripekg:author/RIPEAUC6D85CA026C36CBBMohsen Taghizadeh |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripe:concerns |
ripekg:work/10.1017%2Fs0007114519001132 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripe:rationale |
Investigation by Journal/Publisher;Notice - Limited or No Information |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
ripe:retractionWatchRecordId |
43437 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA084C6EAC9724305F-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA084C6EAC9724305F-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA08F1214EC0C80369-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA08F1214EC0C80369-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA0C83AF9CE6274D42-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA0C83AF9CE6274D42-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA1CF9367F3C1B1AFC-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA1CF9367F3C1B1AFC-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA233158DEF9C3F087-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA233158DEF9C3F087-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA323E9769EC8E8E48-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA323E9769EC8E8E48-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA3DB7B5186353EACB-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA3DB7B5186353EACB-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4A841AC6ADD4DA5B-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4BED4D9BD987577D-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4BED4D9BD987577D-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA534C4E03EC302AE0-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA534C4E03EC302AE0-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA55912887A066C004-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA55912887A066C004-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA56FDC28B3E9006DE-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA56FDC28B3E9006DE-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA69C9C09037F4A7D7-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA69C9C09037F4A7D7-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA84BEB5719212517B-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA84BEB5719212517B-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA85E75680E0A580E5-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA85E75680E0A580E5-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA8DB1A5C7D4B2BCF0-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA8DB1A5C7D4B2BCF0-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA95D9EF8B2CE9BCA4-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA95D9EF8B2CE9BCA4-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA9FB7C0468A11295E-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA9FB7C0468A11295E-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC29393890CA84E8D-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC29393890CA84E8D-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC60164BBD59BB4A3-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC60164BBD59BB4A3-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF6AAC41E3D64BA2C-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF6AAC41E3D64BA2C-inspectai-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF7E1928294A86E83-human-1-3 |
ripekg:retraction-notice/43437Long-term vitamin D and high-dose n-3 fatty acids' supplementation improve markers of cardiometabolic risk in type 2 diabetic patients with CHD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF7E1928294A86E83-inspectai-1-3 |